Preventing psychosis: no one intervention is better than the rest

candice-picard-1111655-unsplash

A group of UCL Mental Health Masters students summarise a recent network meta-analysis that highlights a lack of evidence about specific interventions for preventing psychosis.

[read the full story...]

Physical health inequalities in primary care

list-not-equals

Andy Bell from Centre for Mental Health and the Equally Well UK collaborative, calls for action in response to the Public Health England briefing on severe mental illness and physical health inequalities.

[read the full story...]

Is the incidence of schizophrenia in South-East London really 10 times higher than in Santiago, Spain?

2782048744_3fc0d9280c_b

Vishal Bhavsar reviews an EU study of nearly 3,000 people across 6 EU countries, looking at the treated incidence of schizophrenia and psychotic disorders. It helps us better understand who gets psychosis, when, and where.

[read the full story...]

What can genetics tell us about the link between cannabis and schizophrenia? #MHQT

chase-fade-1055517-unsplash

Suzi Gage summarises a recent GWAS of lifetime cannabis use, which reveals new risk loci, genetic overlap with psychiatric traits, and a causal influence of schizophrenia. Interesting new evidence ahead of our Mental Health Question Time #MHQT event in London tomorrow.

[read the full story...]

Loneliness in psychosis and related psychological and social factors

iz-zy-140216-unsplash

Jingyi Wang publishes her debut blog on a recent systematic review of loneliness in psychosis, which shows that the relationship between loneliness and psychosis remains poorly understood due to a lack of high quality studies.

[read the full story...]

Is Cannabidiol (CBD) an effective antipsychotic?

24281909498_a080b71a94_k

Luke Sheridan Rains publishes his debut blog on a recent multicentre RCT of Cannabidiol (CBD) as an adjunctive therapy for people with schizophrenia, which suggests that CBD had a beneficial, but modest impact on positive psychotic symptoms and severity of illness when used alongside existing antipsychotics.

[read the full story...]

Low dose Amisulpride for very late onset schizophrenia-like psychosis: the ATLAS study

kiwihug-393309-unsplash

Elwira Lubos summarises the recent ATLAS RCT of antipsychotic treatment for very late-onset schizophrenia-like psychosis, which provides evidence for the effectiveness of a very low dose of Amisulpride (100 mg).

[read the full story...]

Inhaling evidence about tobacco and psychosis

maxime-robert-662505-unsplash

Ian Hamilton explores a recent Finnish study of adolescent tobacco smoking and the risk of psychosis, which found that young people aged 15-16 who smoked more than 10 cigarettes a day were three times more likely to have psychosis by the time they reached age 30.

[read the full story...]

Parental homelessness linked to increased risk of mental illness in offspring

brytny-com-617734-unsplash

Dean Connolly explores a Danish register-based cohort study, which investigates the risk of mental health problems in offspring of parents with a history of homelessness during childhood and adolescence.

[read the full story...]

Joint risks? Tobacco and cannabis and psychotic symptoms

joints

James MacCabe appraises a recent study, which looks at the association of combined patterns of tobacco and cannabis use in adolescents who go on to experience psychotic symptoms.

[read the full story...]